ABT CIK: 1800

Abbott Laboratories

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
24.5
FY22:
24.5
FY23:
22.1
FY24:
23.2
FY25:
25.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.43
FY22:
8.36
FY23:
6.48
FY24:
6.83
FY25:
8.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
12.3
FY22:
12.1
FY23:
10.6
FY24:
10.8
FY25:
12.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.21
FY22:
8.31
FY23:
6.66
FY24:
7.01
FY25:
8.47
(positive)
Change from FY21 to FY25
billions USD
FY21:
7.07
FY22:
6.93
FY23:
5.72
FY24:
13.4
FY25:
6.52

All amounts in billions USD Data sources:SEC EDGARTwelve Data